Page last updated: 2024-08-23

substance p and Nervous System Disorders

substance p has been researched along with Nervous System Disorders in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19909 (52.94)18.7374
1990's5 (29.41)18.2507
2000's1 (5.88)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eapen, PM; Nampoothiri, M; Rao, CM1
Grippo, AJ; Scotti, MA1
Bodfish, JW; Dahl, N; Hardrict, R; Kennedy, W; Symons, FJ; Wendelschafer-Crabb, G1
Albuquerque, RH; Bannister, R; Barnes, AJ; Bishop, AE; Bloom, SR; Long, RG; McGregor, GP; O'Shaughnessy, DJ; Polak, JM1
Krieger, DT; Martin, JB1
Neumayr, A1
Ballenger, JC; Bunney, WE; Gold, P; Goodwin, FK; Post, RM; Rubinow, DR1
Blyth, WA; Easty, DL; Hill, TJ; Keen, P; Tullo, AB1
Brown, MR; Buck, SH; Burks, TF; Davis, TP; Walsh, JH; Yamamura, HI1
Beal, MF; Landis, DM; Marshall, PE; Martin, JB; Sagar, SM1
Itoga, E; Kamiya, K; Kishida, K; Kito, S; Yanaihara, N1
Gebhart, GF; Maves, TJ; Meller, ST1
Malek-Ahmadi, P1
Chae, HY; Parvin, CA; Roth, KA; Schmidt, RE1
Apfel, SC; Arezzo, JC; Kessler, JA; Lipton, RB1
Cramer, H; Geiger, J; Jost, S; Milios, E; Mundinger, F; Reuner, C1
Almay, BGL; Johansson, F; Le Grevés, P; Terenius, L; Von Knorring, L1

Reviews

5 review(s) available for substance p and Nervous System Disorders

ArticleYear
Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders.
    Reviews in the neurosciences, 2019, 04-24, Volume: 30, Issue:3

    Topics: Animals; Brain; Humans; Nervous System Diseases; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P

2019
Stress and neuroinflammation.
    Modern trends in pharmacopsychiatry, 2013, Volume: 28

    Topics: Animals; Catecholamines; Cyclooxygenase 2; Cytokines; Glucocorticoids; Humans; Inflammation; Nervous System Diseases; Neuropeptide Y; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Stress, Psychological; Substance P

2013
Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function.
    Life sciences, 1982, Jul-05, Volume: 31, Issue:1

    Topics: Adrenocorticotropic Hormone; Angiotensins; beta-Endorphin; Calcitonin; Endorphins; Humans; Mental Disorders; Nervous System Diseases; Oxytocin; Peptides; Somatostatin; Substance P; Vasoactive Intestinal Peptide; Vasopressins; Vasotocin

1982
Implications of neuropeptides in neurological diseases.
    Peptides, 1984, Volume: 5 Suppl 1

    Topics: Alzheimer Disease; Animals; Brain; Cholecystokinin; Choline O-Acetyltransferase; Endorphins; Epilepsy; Forecasting; Histocytochemistry; Humans; Huntington Disease; Migraine Disorders; Nerve Tissue Proteins; Nervous System Diseases; Pain; Parkinson Disease; Radioimmunoassay; Somatostatin; Substance P; Thyrotropin-Releasing Hormone; Tissue Distribution; Vasopressins

1984
Substance P and neuropsychiatric disorders: an overview.
    Neuroscience and biobehavioral reviews, 1992,Fall, Volume: 16, Issue:3

    Topics: Humans; Mental Disorders; Nervous System Diseases; Substance P

1992

Other Studies

12 other study(ies) available for substance p and Nervous System Disorders

ArticleYear
Evidence of altered epidermal nerve fiber morphology in adults with self-injurious behavior and neurodevelopmental disorders.
    Pain, 2008, Volume: 134, Issue:1-2

    Topics: Adult; Cross-Sectional Studies; Epidermis; Female; Humans; Intellectual Disability; Male; Nerve Fibers; Nervous System Diseases; Self-Injurious Behavior; Substance P

2008
Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure.
    Lancet (London, England), 1980, Mar-15, Volume: 1, Issue:8168 Pt 1

    Topics: Autonomic Nervous System; Biopsy; Chagas Disease; Chronic Disease; Gastrointestinal Hormones; Humans; Intestinal Diseases, Parasitic; Nervous System Diseases; Rectum; Somatostatin; Substance P; Vasoactive Intestinal Peptide

1980
Brain peptides (second of two parts).
    The New England journal of medicine, 1981, Apr-16, Volume: 304, Issue:16

    Topics: Acupuncture Therapy; Animals; Body Temperature Regulation; Brain; Brain Diseases; Cerebrospinal Fluid; Cholecystokinin; Endorphins; Enkephalins; Epilepsy; Feeding Behavior; Humans; Learning; Memory; Nervous System Diseases; Neurotransmitter Agents; Pain; Peptides; Pituitary Hormones; Substance P; Synaptic Transmission

1981
[The APUD concept and its clinical significance. 2. Effect of gastrointestinal hormones, polypeptides and neurotransmitters on the physiological course and disease processes of the intestinal tract and the nervous system].
    Fortschritte der Medizin, 1982, Jun-03, Volume: 100, Issue:21

    Topics: APUD Cells; Cholecystokinin; Hormones; Humans; Intestinal Diseases; Neoplasms; Nervous System Diseases; Neurotensin; Neurotransmitter Agents; Peptides; Substance P

1982
Corneal sensitivity and substance P in experimental herpes simplex keratitis in mice.
    Investigative ophthalmology & visual science, 1983, Volume: 24, Issue:5

    Topics: Animals; Blinking; Keratitis, Dendritic; Male; Muridae; Nervous System Diseases; Sensation; Substance P

1983
Characterization of the peptide and sensory neurotoxic effects of capsaicin in the guinea pig.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1983, Volume: 3, Issue:10

    Topics: Animals; Capsaicin; Cholecystokinin; Dose-Response Relationship, Drug; Ganglia, Spinal; Guinea Pigs; Morphine; Nerve Tissue Proteins; Nervous System Diseases; Neurons, Afferent; Nociceptors; Peripheral Nerves; Somatostatin; Spinal Cord; Substance P; Vasoactive Intestinal Peptide

1983
[Substance P and the nervous system--with special reference to its clinical significance].
    Horumon to rinsho. Clinical endocrinology, 1979, Volume: 27, Issue:2

    Topics: Adult; Animals; Central Nervous System; Female; Humans; Male; Middle Aged; Nervous System Diseases; Rats; Substance P

1979
Neonatal capsaicin treatment prevents the development of the thermal hyperalgesia produced in a model of neuropathic pain in the rat.
    Pain, 1992, Volume: 51, Issue:3

    Topics: Animals; Animals, Newborn; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Hot Temperature; Male; Nervous System Diseases; Pain; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P

1992
Neuroaxonal dystrophy in aging human sympathetic ganglia.
    The American journal of pathology, 1990, Volume: 136, Issue:6

    Topics: Adult; Aged; Aging; Autopsy; Axons; Enkephalin, Methionine; Ganglia, Sympathetic; Gastrin-Releasing Peptide; Humans; Immunohistochemistry; Microscopy, Electron; Middle Aged; Nervous System Diseases; Neurons; Neuropeptide Y; Peptides; Substance P; Synapses; Time Factors; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide

1990
Nerve growth factor prevents toxic neuropathy in mice.
    Annals of neurology, 1991, Volume: 29, Issue:1

    Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Behavior, Animal; Electrophysiology; Ganglia, Spinal; Injections, Intraperitoneal; Male; Mice; Nerve Growth Factors; Nervous System Diseases; Neural Conduction; Neurons, Afferent; Paclitaxel; Reaction Time; Substance P

1991
Ventricular fluid neuropeptides in Parkinson's disease. II. Levels of substance P-like immunoreactivity.
    Neuropeptides, 1991, Volume: 18, Issue:2

    Topics: Adult; Analysis of Variance; Cerebrospinal Fluid Proteins; Chromatography, High Pressure Liquid; Female; Humans; Immunoassay; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Reference Values; Substance P

1991
Substance P in CSF of patients with chronic pain syndromes.
    Pain, 1988, Volume: 33, Issue:1

    Topics: Adult; Aged; Chronic Disease; Depression; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pain; Pain, Intractable; Personality Inventory; Substance P; Syndrome

1988